Oberland Capital

Venture Capital

Oberland Capital is a dedicated healthcare investment firm founded in 2013 and headquartered in New York, with approximately $3.2 billion in assets under management. The firm provides innovative financing solutions — including royalty monetizations, revenue interest financing, and credit facilities — to biopharmaceutical, diagnostic, and medical device companies. Oberland focuses exclusively on the global healthcare industry, targeting commercial-stage and near-commercial-stage companies.

New York, United States · 2+ investments

Late Stage
Growth
Biotech
Healthcare
Medical Devices
Headquarters
New York, United States
Founded
2013
AUM
$3.2B
Total Investments
2
Last Investment
Dec 2025
Geographic Focus
Global

Investment Thesis

Oberland Capital specializes in healthcare royalty and credit investments, providing non-dilutive capital to healthcare companies in exchange for royalties on future revenues or structured credit returns. The firm targets investments of $20 million to $150 million in commercial or near-commercial-stage healthcare companies, with a focus on biopharmaceuticals, diagnostics, and medical devices.

Oberland Capital is a Venture Capital firm based in New York, United States. It has made 2 investments in Biotech and Healthcare.

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Oberland Capital on Indexed.vc
<a href="https://indexed.vc/investors/oberland-capital"><img src="https://indexed.vc/api/badge/investor/oberland-capital" alt="Oberland Capital on Indexed.vc" width="260" height="76" /></a>